title: PHACE syndrome: a retrospective review of 23 patients.
abstract: We present 23 patients with PHACE syndrome showing similarities in our population with data that already exist while highlighting neurodevelopmental occurrences arising in a subset of these patients.
authors.affiliation: Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
authors.forename: Laura E
authors.initials: LE
authors.lastname: Melnick
authors.forename: Albert C
authors.initials: AC
authors.lastname: Yan
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Licht
authors.forename: James R
authors.initials: JR
authors.lastname: Treat
authors.forename: Leslie
authors.initials: L
authors.lastname: Castelo-Soccio
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D001017:Aortic Coarctation / Q000188:drug therapy* / Q000503:physiopathology*; D002648:Child; D002675:Child, Preschool; D005124:Eye Abnormalities / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009420:Nervous System / Q000254:growth & development; D020752:Neurocutaneous Syndromes / Q000188:drug therapy* / Q000503:physiopathology*; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D011433:Propranolol / Q000008:administration & dosage* / Q000009:adverse effects; D012189:Retrospective Studies; D016896:Treatment Outcome; D050257:Tubulin Modulators / Q000008:administration & dosage / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000319:Adrenergic beta-Antagonists; D005938:Glucocorticoids; D050257:Tubulin Modulators; D014750:Vincristine; D011239:Prednisolone; D011433:Propranolol